In short:
New national advice has recommended puberty blockers remain a clinical option for certain children with gender dysphoria.
The medication has been the subject of fierce debate and is restricted in parts of Australia and overseas.
What’s next?
The advice is now open for public consultation with the full national guidelines due in 2028.
0 comments
log in to comment.